These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21393091)

  • 1. The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.
    Djuric M; Kravljanac R; Kovacevic G; Martic J
    Epileptic Disord; 2011 Mar; 13(1):22-6. PubMed ID: 21393091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam in a neonate with malignant migrating partial seizures.
    Hmaimess G; Kadhim H; Nassogne MC; Bonnier C; van Rijckevorsel K
    Pediatr Neurol; 2006 Jan; 34(1):55-9. PubMed ID: 16376281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam.
    Merdariu D; Delanoë C; Mahfoufi N; Bellavoine V; Auvin S
    Brain Dev; 2013 Feb; 35(2):177-80. PubMed ID: 22521903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium bromide for treatment of malignant migrating partial seizures in infancy.
    Ünver O; Incecik F; Dündar H; Kömür M; Ünver A; Okuyaz Ç
    Pediatr Neurol; 2013 Nov; 49(5):355-7. PubMed ID: 23968569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.
    Caraballo RH; Cersósimo R; De los Santos C
    Epileptic Disord; 2010 Jun; 12(2):146-50. PubMed ID: 20483715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam: new preparation. For some patients with refractory partial epilepsy.
    Prescrire Int; 2003 Apr; 12(64):53-4. PubMed ID: 12674114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy of infancy with migrating focal seizures: six patients treated with bromide.
    Caraballo R; Pasteris MC; Fortini PS; Portuondo E
    Seizure; 2014 Nov; 23(10):899-902. PubMed ID: 25044045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
    Piña-Garza JE; Schiemann-Delgado J; Yang H; Duncan B; Hadac J; Hunter SJ
    Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status gelasticus associated with levetiracetam as add-on treatment.
    Pustorino G; Spano M; Sgro DL; Di Rosa G; Tricomi G; Bellantone D; Tortorella G
    Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases.
    Vendrame M; Poduri A; Loddenkemper T; Kluger G; Coppola G; Kothare SV
    Epileptic Disord; 2011 Mar; 13(1):18-21. PubMed ID: 21393094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of levetiracetam in partial seizures.
    Devinsky O; Elger C
    Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catatonia induced by levetiracetam.
    Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
    Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.